<DOC>
	<DOC>NCT00375570</DOC>
	<brief_summary>The Purpose of this study is to evaluate the safety of ME-609 for the treatment of recurrent herpes labialis in adolescents.</brief_summary>
	<brief_title>Safety Study of ME-609 for Treatment of Herpes Simplex Labialis in Adolescents</brief_title>
	<detailed_description>The objective of the study was to evaluate the safety of ME-609 for the treatment of herpes labialis recurrences in immunocompetent adolescents, 12 - 17 years of age, following a 5-day treatment with 5-time daily topical administration.</detailed_description>
	<mesh_term>Herpes Simplex</mesh_term>
	<mesh_term>Herpes Labialis</mesh_term>
	<criteria>General good health History of recurrent herpes labialis with at two recurrences during the last twelve months Treatment with systemic or topical antiviral agents or steroids within two weeks prior to inclusion Significant skin condition that occur in the area of herpes recurrences Nursing or/and pregnancy Immunosupressed state due to underlying disease (e.g. HIV infection or concomitant treatment (e.g. cancer chemotherapy)</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>August 2008</verification_date>
</DOC>